Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antibodies for treatment of amyloid deposition diseases

Chimeric antibodies for treatment of amyloid deposition diseases

US Patent 11530257 · Granted Dec 20, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-CCR2 antibodies and methods of use therefor2015
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplan2014
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplan2013
Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-42012
Humanized anti-CCR2 antibodies and methods of use therefor2012
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplan2010
Humanized anti-CCR2 antibodies and methods of use therefor2009
Humanized anti-CCR2 antibodies and methods of use therefor2009
Humanized anti-CCR2 antibodies and methods of use therefor2008
Humanized anti-VLA4 immunoglobulins2008
Recombinant anti-CCR2 antibodies and methods of use therefor2004
Humanized anti-CCR2 antibodies and methods of use therefor2004